B
Bionexo
Electronic community linking hospitals, pharmaceutical industry, distributors and other healthcare area suppliers
About Bionexo
Bionexo operates as a key technology provider within the Latin American healthcare sector, offering a suite of digital solutions for managing processes in hospitals, clinics, and for healthcare suppliers. Founded in 2000 by Mauricio De Lazzari Barbosa and Marcelo Salinas, the company originated with backing from a business accelerator financed by Santander, aiming to create marketplaces across different industries. Following the dot-com bubble, Barbosa and Salinas acquired the company, pioneering an online marketplace to streamline procurement for hospitals.
The company's core business revolves around a Software as a Service (SaaS) model, providing a B2B healthcare marketplace that connects thousands of healthcare institutions with suppliers. This platform facilitates the procurement of a wide range of items from medications and medical supplies to food and cleaning products, aiming to increase efficiency and transparency in the supply chain. Revenue is generated primarily through subscriptions rather than a take-rate on transactions. Bionexo's client base includes over 3,500 healthcare institutions and more than 30,000 suppliers across Brazil, Argentina, Colombia, and Mexico.
Over the years, Bionexo has expanded its portfolio beyond its initial marketplace. It now offers integrated solutions for digital inventory management, revenue cycle management, and data analytics. This expansion has been fueled by strategic acquisitions, including companies like Avatar, BeeCare, Síntese, and Tradimus, which have enhanced its capabilities in revenue cycle management, ERP for clinics, and marketplace consolidation. Significant funding rounds, notably from investors like Bain Capital, Insight Partners, and Temasek, have supported this growth strategy, enabling the company to pursue M&A opportunities and invest in technology such as artificial intelligence.
The company's solutions are designed to digitize and automate the entire healthcare value chain, from purchase planning and supply transactions to processing medical bills. For hospitals and clinics, this translates into productivity gains and cost savings. For suppliers, it offers more efficient sales processes and access to a broader market. Bionexo has also developed specific solutions like OPMEnexo, for regulating the acquisition of prosthetics and orthotics, and offers tools for tracking high-cost materials. The platform processes billions in transactions annually and continues to evolve by embedding more computational intelligence to automate and simplify processes for its users.
Source: Dealroom company dataAt a glance
- Founded
- 2000
- Headquarters
- São Paulo, Brazil
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later4 investors entered at this stage
Insight Partners
Temasek
Bain Capital
Bain Capital Tech Opportunities
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Bionexo on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bionexo on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.